drugset / Trial / NCT00513565

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

NCT00513565

Phase 1 Completed 22 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindDiagnostic

Summary

This study will be conducted in healthy volunteers to investigate the effect of single dose GSK561679 on the changes of brain activation, as it compares to an active comparator, lorazepam.

Timeline

Start
2007-09-13
Primary completion
2009-05-14
Completion
2009-05-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule
Subject VERUCERFONT Small molecule